skip to Main Content

March 27, 2019, Wednesday: Strategies for Celgene Stockholders: Part II

1 min read

An informative session with RegentAtlantic Chad O’Brien, CFP®, FRM and Abby Rosen, CFP®, MS

Bristol-Myers Squibb’s acquisition of Celgene may generate a significant tax burden for Celgene stockholders.

Join our 30 minute webinar

  • Examples of taxability for Celgene shareholders
  • Update on strategies to reduce taxes
  • What you can do to prepare as an employee
  • How Celgene stock options will be impacted

Click a time below to register

This session is not a substitute for personalized advice from RegentAtlantic. Please be sure to consult with your tax or legal advisors.

Back To Top